Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | N/A | -1,301,600 | N/A | N/A |
| Depreciation Amortization | 0 | N/A | 2,374,650 | N/A | N/A |
| Other Working Capital | 0 | N/A | 1,658,980 | N/A | N/A |
| Other Operating Activity | 0 | 0 | -1,071,130 | 0 | 0 |
| Operating Cash Flow | $0 | $N/A | $1,660,900 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | -130,390 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 961,640 | 0 | 0 |
| Investing Cash Flow | $0 | $N/A | $831,250 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | N/A | -1,288,890 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -1,450,190 | 0 | 0 |
| Financing Cash Flow | $0 | $N/A | $-2,739,080 | $N/A | $N/A |
| Exchange Rate Effect | 0 | N/A | 148,590 | N/A | N/A |
| Beginning Cash Position | 0 | N/A | 6,061,030 | N/A | N/A |
| End Cash Position | 0 | N/A | 5,962,710 | N/A | N/A |
| Net Cash Flow | $0 | $N/A | $-98,320 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | N/A | 1,660,900 | N/A | N/A |
| Free Cash Flow | 0 | 0 | 1,660,900 | 0 | 0 |